Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

RNA Sequencing Data-Driven Dissection of Human Plasma Cell Differentiation Reveals New Potential Transcription Regulators

Alboukadel Kassambara, PhD, Laurie Herviou, Michel Jourdan, Coraline Thibaut, Veronika Vikova, Olivier Elemento, PhD, Jerome Moreaux, PhD

Blood (2017) 130 (Supplement 1): 4382.

https://doi.org/10.1182/blood.V130.Suppl_1.4382.4382

Published: 2017

Journal Articles

On the Redox Profile of B- Cell Terminal Differentiation and Multiple Myeloma: New Insights and Therapeutic Opportunities

Wafa Hassen, PhD, Alboukadel Kassambara, PhD, Michel Jourdan, Stephanie Boireau, PhD, Anja Seckinger, MD, Dirk Hose, Yubin Kang, MD, Bernard Klein, Jerome Moreaux, PhD

Blood (2016) 128 (22): 5644.

https://doi.org/10.1182/blood.V128.22.5644.5644

Published: 2016

Journal Articles

Patterns of Microrna in Plasma Cells: From Normal Differentiation to Multiple Myeloma

Alboukadel Kassambara, PhD, Angelique Bruyer, Michel Jourdan, Nicolas Robert, Véronique Pantesco, Olivier Elemento, PhD, Bernard Klein, Jerome Moreaux, PhD

Blood (2016) 128 (22): 2069.

https://doi.org/10.1182/blood.V128.22.2069.2069

Published: 2016

Journal Articles

An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization

Michel Jourdan, Anouk Caraux, John De Vos, Geneviève Fiol, Marion Larroque, Chantal Cognot, Caroline Bret, Christophe Duperray, Dirk Hose, Bernard Klein

Blood (2009) 114 (25): 5173–5181.

https://doi.org/10.1182/blood-2009-07-235960

Published: 2009

Includes: Supplemental data

Journal Articles

An in Vitro Model of Differentiation of Memory B Cells Into Plasmablasts and Plasma Cells Including Detailed Phenotypic and Molecular Characterization.

Michel Jourdan, Anouk Caraux, John De Vos, PhD, Geneviève Fiol, Marion Larroque, Chantal Cognot, Caroline Bret, Christophe Duperray, Dirk Hose, Bernard Klein

Blood (2009) 114 (22): 1636.

https://doi.org/10.1182/blood.V114.22.1636.1636

Published: 2009

Journal Articles

The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor

Anne Catherine Sprynski, Dirk Hose, Laurent Caillot, Thierry Réme, John D. Shaughnessy, Jr, Bart Barlogie, Anja Seckinger, Jérôme Moreaux, Michael Hundemer, Michel Jourdan, Tobias Meißner, Anna Jauch, Karène Mahtouk, Alboukadel Kassambara, Uta Bertsch, Jean François Rossi, Hartmut Goldschmidt, Bernard Klein

Blood (2009) 113 (19): 4614–4626.

https://doi.org/10.1182/blood-2008-07-170464

Published: 2009

Journal Articles

Unsupervised Analysis of Gene Expression Profile of 37 Human Myeloma Cell Lines Identifies 5 Classes of HMCL Characterized by a Set of 213 Genes Related to Molecular Classification of Patients with Multiple Myeloma

Jerome Moreaux, Bernard Klein, Thierry Reme, Michel Jourdan, Sophie Maiga, Régis Bataille, Martine Amiot, Catherine Pellat-Deceunynck

Blood (2008) 112 (11): 2702.

https://doi.org/10.1182/blood.V112.11.2702.2702

Published: 2008

Journal Articles

Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma

Karène Mahtouk, Dirk Hose, Pierre Raynaud, Michael Hundemer, Michel Jourdan, Eric Jourdan, Veronique Pantesco, Marion Baudard, John De Vos, Marion Larroque, Thomas Moehler, Jean-Francois Rossi, Thierry Rème, Hartmut Goldschmidt, Bernard Klein

Blood (2007) 109 (11): 4914–4923.

https://doi.org/10.1182/blood-2006-08-043232

Published: 2007

Journal Articles

Inhibition of Multiple Myeloma Cells Growth by AS602868, a Pharmacological Inhibitor of IKK2.

Michel Jourdan, PhD, Jerome Moreaux, PhD, Dirk Hose, MD, Jean-Francois Rossi, MD, PhD, Karène Mahtouk, PhD, Mathieu Aboulaze, Nicolas Robert, Marion Baudard, MD, PhD, Thierry Reme, MD, PhD, Angela Romanelli, Hartmut Goldschmidt, MD, Michel Dreano, PhD, Bernard Klein, MD, PhD

Blood (2006) 108 (11): 3472.

https://doi.org/10.1182/blood.V108.11.3472.3472

Published: 2006

Journal Articles

Heparanase Influences Expression and Shedding of Syndecan-1, and Its Expression by the Bone Marrow Environment Is a Bad Prognostic Factor in Multiple Myeloma.

Karene Mahtouk, Dirk Hose, Thierry Reme, Michael Hundemer, Michel Jourdan, Eric Jourdan, Veronique Pantesco, Marion Baudard, John De Vos, Marion Larroque, Thomas Moehler, Jean-Francois Rossi, Hartmut Goldschmidt, Bernard Klein

Blood (2006) 108 (11): 3502.

https://doi.org/10.1182/blood.V108.11.3502.3502

Published: 2006

Journal Articles

Syndecan-1 Is Essential for the Myeloma Cell Growth Factor Activity of EGF-Family Ligands in Multiple Myeloma.

Karène Mahtouk, Friedrich W. Cremer, Thierry Rème, Michel Jourdan, Marion Baudard, Jérome Moreaux, Guilhem Requirand, Geneviève Fiol, John De Vos, Marion Moos, Philippe Quittet, Hartmut Goldschmidt, Jean-Francois Rossi, Dirk Hose, Bernard Klein

Blood (2005) 106 (11): 626.

https://doi.org/10.1182/blood.V106.11.626.626

Published: 2005

Journal Articles

Amphiregulin Is Produced by Myeloma Cells and Is Involved in Tumor-Environment Interactions in Multiple Myeloma.

Karène Mahtouk, Dirk Hose, Thierry Reme, John De Vos, Michel Jourdan, Jérome Moreaux, Geneviève Fiol, Marc Raab, Eric Jourdan, Marion Moos, Hartmut Goldschmidt, Jean-François Rossi, Friedrich W. Cremer, Bernard Klein

Blood (2004) 104 (11): 4306.

https://doi.org/10.1182/blood.V104.11.4306.4306

Published: 2004

Journal Articles

An inhibitor of the EGF receptor family blocks myeloma cell growth factor activity of HB-EGF and potentiates dexamethasone or anti–IL-6 antibody-induced apoptosis

Karène Mahtouk, Michel Jourdan, John De Vos, Catherine Hertogh, Geneviève Fiol, Eric Jourdan, Jean-François Rossi, Bernard Klein

Blood (2004) 103 (5): 1829–1837.

https://doi.org/10.1182/blood-2003-05-1510

Published: 2004

Journal Articles

Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays

John De Vos, Guilhem Couderc, Karin Tarte, Michel Jourdan, Guilhem Requirand, Marie-Claude Delteil, Jean-François Rossi, Nadir Mechti, Bernard Klein

Blood (2001) 98 (3): 771–780.

https://doi.org/10.1182/blood.V98.3.771

Published: 2001

Journal Articles

Kaposi’s Sarcoma-Associated Herpesvirus Is Not Detected With Immunosuppression in Multiple Myeloma

Karin Tarte, Sonja J. Olsen, Jean-François Rossi, Eric Legouffe, Zhao-Yang Lu, Michel Jourdan, Yuan Chang, Bernard Klein

Blood (1998) 92 (6): 2186–2188.

https://doi.org/10.1182/blood.V92.6.2186

Published: 1998

NARROW

RNA Sequencing Data-Driven Dissection of Human Plasma Cell Differentiation Reveals New Potential Transcription Regulators

On the Redox Profile of B- Cell Terminal Differentiation and Multiple Myeloma: New Insights and Therapeutic Opportunities

Patterns of Microrna in Plasma Cells: From Normal Differentiation to Multiple Myeloma

An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization

An in Vitro Model of Differentiation of Memory B Cells Into Plasmablasts and Plasma Cells Including Detailed Phenotypic and Molecular Characterization.

The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor

Unsupervised Analysis of Gene Expression Profile of 37 Human Myeloma Cell Lines Identifies 5 Classes of HMCL Characterized by a Set of 213 Genes Related to Molecular Classification of Patients with Multiple Myeloma

Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma

Inhibition of Multiple Myeloma Cells Growth by AS602868, a Pharmacological Inhibitor of IKK2.

Heparanase Influences Expression and Shedding of Syndecan-1, and Its Expression by the Bone Marrow Environment Is a Bad Prognostic Factor in Multiple Myeloma.

Syndecan-1 Is Essential for the Myeloma Cell Growth Factor Activity of EGF-Family Ligands in Multiple Myeloma.

Amphiregulin Is Produced by Myeloma Cells and Is Involved in Tumor-Environment Interactions in Multiple Myeloma.

An inhibitor of the EGF receptor family blocks myeloma cell growth factor activity of HB-EGF and potentiates dexamethasone or anti–IL-6 antibody-induced apoptosis

Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays

Kaposi’s Sarcoma-Associated Herpesvirus Is Not Detected With Immunosuppression in Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only